Skip to main content
. 2020 Aug 19;9(20):7407–7417. doi: 10.1002/cam4.3383

Figure 5.

Figure 5

Copy number alteration (CNA) count of clear cell ovarian cancers in stage I and advanced stage (II, III, IV). *, P < .05. (A). Progression‐free survival (PFS) and overall survival (OS) analysis in CNA high (CNA count ≥ 30) and CNA low (CNA count < 30) clear cell ovarian cancers. **, P < .01. (B). CNA count of all malignant ovarian tumors in stage I and advanced stage (II, III, IV). ***, P < .005. (C). PFS and OS analysis of CNA high (CNA count ≥ 30) and CNA low (CNA count < 30) for all malignant ovarian tumors. *, P < .05; ***, P < .005. (D)